These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 19475551

  • 1. Papillary microcarcinoma in comparison with larger papillary thyroid carcinoma in BRAF(V600E) mutation, clinicopathological features, and immunohistochemical findings.
    Park YJ, Kim YA, Lee YJ, Kim SH, Park SY, Kim KW, Chung JK, Youn YK, Kim KH, Park DJ, Cho BY.
    Head Neck; 2010 Jan; 32(1):38-45. PubMed ID: 19475551
    [Abstract] [Full Text] [Related]

  • 2. BRAFV600E mutation and X-linked inhibitor of apoptosis expression in papillary thyroid carcinoma.
    Gu LQ, Li FY, Zhao L, Liu Y, Zang XX, Wang TX, Chen HP, Ning G, Zhao YJ.
    Thyroid; 2009 Apr; 19(4):347-54. PubMed ID: 19355825
    [Abstract] [Full Text] [Related]

  • 3. [Invasiveness of papillary thyroid microcarcinoma with BRAF mutation].
    Yang X, Liang ZY, Meng C, Liang J, Yu Z, Lin YS.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2013 Aug; 35(4):398-403. PubMed ID: 23987486
    [Abstract] [Full Text] [Related]

  • 4. [Clinical pathological characteristics of resectable papillary thyroid microcarcinoma].
    Shi CL, Guo Y, Lyu YC, Nanding ZABYS, Gao WC, Shi TF, Qin HD, Liu SY.
    Zhonghua Zhong Liu Za Zhi; 2017 May 23; 39(5):361-366. PubMed ID: 28535653
    [Abstract] [Full Text] [Related]

  • 5. Influence of the BRAF V600E mutation on expression of vascular endothelial growth factor in papillary thyroid cancer.
    Jo YS, Li S, Song JH, Kwon KH, Lee JC, Rha SY, Lee HJ, Sul JY, Kweon GR, Ro HK, Kim JM, Shong M.
    J Clin Endocrinol Metab; 2006 Sep 23; 91(9):3667-70. PubMed ID: 16772349
    [Abstract] [Full Text] [Related]

  • 6. The role of BRAF V600E mutation as a potential marker for prognostic stratification of papillary thyroid carcinoma: a long-term follow-up study.
    Daliri M, Abbaszadegan MR, Bahar MM, Arabi A, Yadollahi M, Ghafari A, Taghehchian N, Zakavi SR.
    Endocr Res; 2014 Sep 23; 39(4):189-93. PubMed ID: 24679337
    [Abstract] [Full Text] [Related]

  • 7. BRAF(V600E) mutation and outcome of patients with papillary thyroid carcinoma: a 15-year median follow-up study.
    Elisei R, Ugolini C, Viola D, Lupi C, Biagini A, Giannini R, Romei C, Miccoli P, Pinchera A, Basolo F.
    J Clin Endocrinol Metab; 2008 Oct 23; 93(10):3943-9. PubMed ID: 18682506
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. BRAF mutation associated with other genetic events identifies a subset of aggressive papillary thyroid carcinoma.
    Costa AM, Herrero A, Fresno MF, Heymann J, Alvarez JA, Cameselle-Teijeiro J, García-Rostán G.
    Clin Endocrinol (Oxf); 2008 Apr 23; 68(4):618-34. PubMed ID: 18070147
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Quantification of BRAF V600E alleles predicts papillary thyroid cancer progression.
    Kim MH, Bae JS, Lim DJ, Lee H, Jeon SR, Park GS, Jung CK.
    Endocr Relat Cancer; 2014 Apr 23; 21(6):891-902. PubMed ID: 25266729
    [Abstract] [Full Text] [Related]

  • 12. BRAF (V600E) mutation analysis in papillary thyroid carcinomas by peptide nucleic acid clamp real-time PCR.
    Jeong D, Jeong Y, Park JH, Han SW, Kim SY, Kim YJ, Kim SJ, Hwangbo Y, Park S, Cho HD, Oh MH, Yang SH, Kim CJ.
    Ann Surg Oncol; 2013 Mar 23; 20(3):759-66. PubMed ID: 23179992
    [Abstract] [Full Text] [Related]

  • 13. Associations of the BRAF(V600E) mutation with sonographic features and clinicopathologic characteristics in a large population with conventional papillary thyroid carcinoma.
    Park AY, Son EJ, Kim JA, Youk JH, Park YJ, Park CS, Chang HS.
    PLoS One; 2014 Mar 23; 9(10):e110868. PubMed ID: 25337709
    [Abstract] [Full Text] [Related]

  • 14. Significance of p53-binding protein 1 (53BP1) expression in thyroid papillary microcarcinoma: association with BRAFV600E mutation status.
    Mussazhanova Z, Matsuda K, Naruke Y, Mitsutake N, Stanojevic B, Rougounovitch T, Saenko V, Suzuki K, Nishihara E, Hirokawa M, Ito M, Nakashima M.
    Histopathology; 2013 Nov 23; 63(5):726-34. PubMed ID: 24004175
    [Abstract] [Full Text] [Related]

  • 15. Correlation between B-RAFV600E mutation and clinico-pathologic parameters in papillary thyroid carcinoma: data from a multicentric Italian study and review of the literature.
    Fugazzola L, Puxeddu E, Avenia N, Romei C, Cirello V, Cavaliere A, Faviana P, Mannavola D, Moretti S, Rossi S, Sculli M, Bottici V, Beck-Peccoz P, Pacini F, Pinchera A, Santeusanio F, Elisei R.
    Endocr Relat Cancer; 2006 Jun 23; 13(2):455-64. PubMed ID: 16728573
    [Abstract] [Full Text] [Related]

  • 16. Clinicopathological Features and Prognosis of Papillary Thyroid Microcarcinoma for Surgery and Relationships with the BRAFV600E Mutational Status and Expression of Angiogenic Factors.
    Shi C, Guo Y, Lv Y, Nanding A, Shi T, Qin H, He J.
    PLoS One; 2016 Jun 23; 11(12):e0167414. PubMed ID: 27936049
    [Abstract] [Full Text] [Related]

  • 17. Clinical and pathological features and the BRAF(V600E) mutation in patients with papillary thyroid carcinoma with and without concurrent Hashimoto thyroiditis.
    Kim SK, Song KH, Lim SD, Lim YC, Yoo YB, Kim JS, Hwang TS.
    Thyroid; 2009 Feb 23; 19(2):137-41. PubMed ID: 19014278
    [Abstract] [Full Text] [Related]

  • 18. Molecular Profiling of Papillary Thyroid Carcinoma in Korea with a High Prevalence of BRAFV600E Mutation.
    Lee SE, Hwang TS, Choi YL, Kim WY, Han HS, Lim SD, Kim WS, Yoo YB, Kim SK.
    Thyroid; 2017 Jun 23; 27(6):802-810. PubMed ID: 28293988
    [Abstract] [Full Text] [Related]

  • 19. BRAF V600E and decreased NIS and TPO expression are associated with aggressiveness of a subgroup of papillary thyroid microcarcinoma.
    Bastos AU, Oler G, Nozima BH, Moysés RA, Cerutti JM.
    Eur J Endocrinol; 2015 Oct 23; 173(4):525-40. PubMed ID: 26338373
    [Abstract] [Full Text] [Related]

  • 20. Expressions of miRNAs in papillary thyroid carcinoma and their associations with the BRAFV600E mutation.
    Huang Y, Liao D, Pan L, Ye R, Li X, Wang S, Ye C, Chen L.
    Eur J Endocrinol; 2013 May 23; 168(5):675-81. PubMed ID: 23416953
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.